Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review

Imagem de Miniatura
Arquivos
art_PAULA_Protective_or_Inhibitory_Effect_of_Pharmacological_Therapy_on_2022.PDF (2.02 MB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BENTHAM SCIENCE PUBL LTD
Autores
UCHIDA, Augusto Hiroshi
Citação
CURRENT VASCULAR PHARMACOLOGY, v.20, n.5, p.409-428, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Ischemic preconditioning (IP) is an innate phenomenon, triggered by brief, non-lethal cycles of ischemia/reperfusion applied to a tissue or organ that confers tolerance to a subsequent more prolonged ischemic event. Once started, it can reduce the severity of myocardial ischemia associated with some clinical situations, such as percutaneous coronary intervention (PCI) and intermittent aortic clamping during coronary artery bypass graft surgery (CABG). Although the mechanisms underlying IP have not been completely elucidated, several studies have shown that this phenomenon involves the participation of cell triggers, intracellular signaling pathways, and end-effectors. Understanding this mechanism enables the development of preconditioning mimetic agents. It is known that a range of medications that activate the signaling cascades at different cellular levels can interfere with both the stimulation and the blockade of IP. Investigations of signaling pathways underlying ischemic conditioning have identified a number of therapeutic targets for pharmacological manipulation. This review aims to present and discuss the effects of several medications on myocardial IP.
Palavras-chave
Ischemic preconditioning, cardiac pharmacology, ischemia-reperfusion injury, heart disease, signaling pathways, cardioprotection
URI
https://observatorio.fm.usp.br/handle/OPI/51783
Referências
  1. Abe J, 2000, CIRC RES, V86, P607, DOI 10.1161/01.RES.86.6.607
  2. Ahmed LA, 2011, EUR J PHARMACOL, V663, P51, DOI 10.1016/j.ejphar.2011.04.038
  3. AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203
  4. Amr YM, 2010, SEMIN CARDIOTHORAC V, V14, P205, DOI 10.1177/1089253210376839
  5. Argaud L, 2005, J MOL CELL CARDIOL, V39, P893, DOI 10.1016/j.yjmcc.2005.09.012
  6. Auchampach John A., 1993, American Journal of Physiology, V264, pH1327
  7. Baines CP, 1999, BASIC RES CARDIOL, V94, P188, DOI 10.1007/s003950050142
  8. Baines CP, 1997, J MOL CELL CARDIOL, V29, P207, DOI 10.1006/jmcc.1996.0265
  9. Baines CP, 1998, J MOL CELL CARDIOL, V30, P383, DOI 10.1006/jmcc.1997.0601
  10. Baker HE, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0733-2
  11. BALL SG, 1993, LANCET, V342, P821
  12. Ovunc K, 2000, CLIN CARDIOL, V23, P535
  13. Ozawa T, 2010, CIRC J, V74, P1415, DOI 10.1253/circj.CJ-10-0109
  14. Pache J, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.01.019
  15. Paiva M, 2009, J CARDIOVASC PHARM, V53, P373, DOI 10.1097/FJC.0b013e31819fd4e7
  16. Parsa CJ, 2004, J BIOL CHEM, V279, P20655, DOI 10.1074/jbc.M314099200
  17. Parvin AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107453
  18. Patterson D, 2005, BRIT J CLIN PHARMACO, V60, P459, DOI 10.1111/j.1365-2125.2005.02479.x
  19. Patti G, 2011, CIRCULATION, V123, P1622, DOI 10.1161/CIRCULATIONAHA.110.002451
  20. Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008
  21. Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023
  22. Imagawa J, 1998, J CARDIOVASC PHARM, V31, P74, DOI 10.1097/00005344-199801000-00011
  23. PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
  24. Pravdic D, 2009, ANESTHESIOLOGY, V111, P267, DOI 10.1097/ALN.0b013e3181a91957
  25. Prunier F, 2012, AM HEART J, V163, P200, DOI 10.1016/j.ahj.2011.11.005
  26. Putzu A, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0441-3
  27. Rahmi RM, 2013, DIABETES CARE, V36, P1654, DOI 10.2337/dc12-1495
  28. Read PA, 2012, HEART, V98, P408, DOI 10.1136/hrt.2010.219345
  29. Read PA, 2011, CIRC-CARDIOVASC INTE, V4, P266, DOI 10.1161/CIRCINTERVENTIONS.110.960476
  30. Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167
  31. Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061
  32. Rossello X, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-017-0662-x
  33. Imagawa J, 1997, J MOL CELL CARDIOL, V29, P1885, DOI 10.1006/jmcc.1997.0428
  34. Bilinska M, 2007, CORONARY ARTERY DIS, V18, P455, DOI 10.1097/MCA.0b013e3282a30676
  35. Rossello X, 2018, J CELL MOL MED, V22, P926, DOI 10.1111/jcmm.13394
  36. Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979
  37. Sarraf M, 2012, CARDIOVASC DRUG THER, V26, P195, DOI 10.1007/s10557-012-6384-2
  38. Sasaki H, 2007, INT HEART J, V48, P623, DOI 10.1536/ihj.48.623
  39. Sasaki H, 1999, ANTIOXID REDOX SIGN, V1, P317, DOI 10.1089/ars.1999.1.3-317
  40. Schaefer U, 2007, J INTERN MED, V261, P188, DOI 10.1111/j.1365-2796.2006.01757.x
  41. Schultz Jo El J., 1995, American Journal of Physiology, V268, pH2157
  42. Schulz R, 2001, AM J PHYSIOL-HEART C, V280, pH2175, DOI 10.1152/ajpheart.2001.280.5.H2175
  43. SEBBAG L, 1994, J AM COLL CARDIOL, V24, P1580, DOI 10.1016/0735-1097(94)90158-9
  44. Iskesen I, 2006, CIRC J, V70, P1169, DOI 10.1253/circj.70.1169
  45. Seo WW, 2019, INT HEART J, V60, P255, DOI 10.1536/ihj.18-035
  46. Blanc P, 2001, BRIT J ANAESTH, V87, P848, DOI 10.1093/bja/87.6.848
  47. Sesti C, 2007, INT J IMPOT RES, V19, P55, DOI 10.1038/sj.ijir.3901497
  48. Sheth S, 2014, INT J MOL SCI, V15, P2024, DOI 10.3390/ijms15022024
  49. Shi Y, 2021, MOL MED REP, V24, DOI 10.3892/mmr.2021.12351
  50. Shi ZW, 2015, AM J PHYSIOL-HEART C, V308, pH281, DOI 10.1152/ajpheart.00666.2014
  51. Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197
  52. Shinmura K, 2003, J AM COLL CARDIOL, V41, P1183, DOI 10.1016/S0735-1097(03)00086-X
  53. Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57
  54. Shinmura K, 2002, AM J PHYSIOL-HEART C, V283, pH2534, DOI 10.1152/ajpheart.00209.2002
  55. Issa K, 2013, CRIT CARE, V17, DOI 10.1186/cc12808
  56. Simkhovich BZ, 1998, CARDIOVASC RES, V40, P9, DOI 10.1016/S0008-6363(98)00142-4
  57. Simoncini T, 2002, CIRCULATION, V105, P1368, DOI 10.1161/hc1102.105267
  58. Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5
  59. Sivarajah A, 2009, SHOCK, V31, P267, DOI 10.1097/SHK.0b013e318180ff89
  60. Sivaraman V, 2014, J CARDIOVASC PHARM T, V19, P83, DOI 10.1177/1074248413499973
  61. Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157
  62. Soboleva G, 2020, EUR HEART J, V41, P1463
  63. Solskov L, 2008, BASIC CLIN PHARMACOL, V103, P82, DOI 10.1111/j.1742-7843.2008.00234.x
  64. Song KX, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/287058
  65. Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067
  66. Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044
  67. Sun WX, 2019, EXP THER MED, V17, P2230, DOI 10.3892/etm.2019.7164
  68. SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002
  69. Szilvassy Z, 1997, BRIT J PHARMACOL, V121, P491, DOI 10.1038/sj.bjp.0701163
  70. Bonanni A, 2020, ANESTHESIOLOGY, V132, P1429, DOI 10.1097/ALN.0000000000003236
  71. Tanajak P, 2018, J ENDOCRINOL, V236, P69, DOI 10.1530/JOE-17-0457
  72. Tang XL, 2004, AM J PHYSIOL-HEART C, V286, pH1273, DOI 10.1152/ajpheart.01055.2003
  73. Taniguchi N, 2010, CIRC J, V74, P2365, DOI 10.1253/circj.CJ-10-0267
  74. Thadani U, 2002, J AM COLL CARDIOL, V40, P2006, DOI 10.1016/S0735-1097(02)02563-9
  75. THORNTON JD, 1993, AM J PHYSIOL, V265, pH504, DOI 10.1152/ajpheart.1993.265.2.H504
  76. Timmer JR, 2006, J AM COLL CARDIOL, V47, P1730, DOI 10.1016/j.jacc.2006.01.040
  77. Jiang XJ, 2006, LIFE SCI, V78, P2543, DOI 10.1016/j.lfs.2005.10.032
  78. Timmers L, 2007, CIRCULATION, V115, P326, DOI 10.1161/CIRCULATIONAHA.106.647230
  79. Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033
  80. Toldo S, 2014, CIRC-CARDIOVASC GENE, V7, P311, DOI 10.1161/CIRCGENETICS.113.000381
  81. Tomai F, 1999, EUR HEART J, V20, P196, DOI 10.1053/euhj.1998.1311
  82. Bonnemeier H, 2007, PACE, V30, pS160
  83. Tomai F, 1999, J AM COLL CARDIOL, V33, P1863, DOI 10.1016/S0735-1097(99)00095-9
  84. Tomai F, 1997, CIRCULATION, V96, P2171
  85. Tomai F, 1999, CIRCULATION, V100, P559, DOI 10.1161/01.CIR.100.5.559
  86. TOMAI F, 1994, CIRCULATION, V90, P700, DOI 10.1161/01.CIR.90.2.700
  87. TOOMBS CF, 1993, CARDIOVASC RES, V27, P617, DOI 10.1093/cvr/27.4.617
  88. Jiao XF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224562
  89. Tritto I, 1997, CIRC RES, V80, P743, DOI 10.1161/01.RES.80.5.743
  90. Tsuchida A, 2002, J AM COLL CARDIOL, V40, P1523, DOI 10.1016/S0735-1097(02)02268-4
  91. Ungi I, 2008, CAN J PHYSIOL PHARM, V86, P827, DOI 10.1139/Y08-096
  92. Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958
  93. Vahlhaus C, 1998, J MOL CELL CARDIOL, V30, P197, DOI 10.1006/jmcc.1997.0609
  94. Bose AK, 2005, CARDIOVASC DRUG THER, V19, P9, DOI 10.1007/s10557-005-6892-4
  95. Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8
  96. van der Horst ICC, 2003, J AM COLL CARDIOL, V42, P784, DOI 10.1016/S0735-1097(03)00830-1
  97. van Giezen JJJ, 2012, J CARDIOVASC PHARM T, V17, P164, DOI 10.1177/1074248411410883
  98. Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092
  99. Jonassen AK, 2001, CIRC RES, V89, P1191, DOI 10.1161/hh2401.101385
  100. VEGH A, 1991, BRIT J PHARMACOL, V104, P294, DOI 10.1111/j.1476-5381.1991.tb12424.x
  101. VEGH A, 1993, BRIT J PHARMACOL, V110, P18, DOI 10.1111/j.1476-5381.1993.tb13764.x
  102. Verouhis D, 2021, J CARDIOVASC PHARM T, V26, P253, DOI 10.1177/1074248420968693
  103. Vogt AM, 1997, CARDIOVASC RES, V33, P469, DOI 10.1016/S0008-6363(96)00212-X
  104. Voors AA, 2010, EUR HEART J, V31, P2593, DOI 10.1093/eurheartj/ehq304
  105. WALL TM, 1994, J PHARMACOL EXP THER, V270, P681
  106. Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146
  107. Wang HX, 2021, KOREAN J PHYSIOL PHA, V25, P239, DOI 10.4196/kjpp.2021.25.3.239
  108. Wang J, 2013, SCAND CARDIOVASC J, V47, P175, DOI 10.3109/14017431.2012.760749
  109. Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp
  110. Alburquerque-Bejar JJ, 2015, CARDIOVASC RES, V107, P246, DOI 10.1093/cvr/cvv171
  111. Wang XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182777
  112. Wang X, 2009, SCAND CARDIOVASC J, V43, P72, DOI 10.1080/14017430802180449
  113. Wasir H, 2001, EUR J CARDIO-THORAC, V19, P41, DOI 10.1016/S1010-7940(00)00605-9
  114. Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389
  115. Wong GTC, 2010, J CARDIOTHOR VASC AN, V24, P790, DOI 10.1053/j.jvca.2009.09.012
  116. Wu H, 2015, CELL PHYSIOL BIOCHEM, V35, P2320, DOI 10.1159/000374035
  117. Xiao X, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7042105
  118. Bouida W, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006674
  119. Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002
  120. Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522
  121. Joyeux-Faure M, 2012, FUND CLIN PHARMACOL, V26, P761, DOI 10.1111/j.1472-8206.2011.00992.x
  122. Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798
  123. Xuan YT, 1999, CIRC RES, V84, P1095, DOI 10.1161/01.RES.84.9.1095
  124. Yang J, 2003, MOL THER, V7, P341, DOI 10.1016/S1525-0016(02)00061-8
  125. Yang XM, 2006, BASIC RES CARDIOL, V101, P311, DOI 10.1007/s00395-006-0587-2
  126. Yang XM, 2013, CARDIOVASC DRUG THER, V27, P403, DOI 10.1007/s10557-013-6474-9
  127. Yang XP, 2005, ARTERIOSCL THROM VAS, V25, P1395, DOI 10.1161/01.ATV.0000168428.96177.24
  128. Yazici M, 2005, AM J CARDIOL, V96, P1517, DOI 10.1016/j.amjcard.2005.07.060
  129. Ye YM, 2015, ARTERIOSCL THROM VAS, V35, P1805, DOI 10.1161/ATVBAHA.115.305655
  130. Bremer YA, 2005, PEDIATR RES, V57, P22, DOI 10.1203/01.PDR.0000147736.27672.15
  131. Ye ZL, 2018, DRUG DES DEV THER, V12, P2591, DOI 10.2147/DDDT.S173931
  132. Ban K, 2008, CIRC RES, V103, P643, DOI 10.1161/CIRCRESAHA.108.175018
  133. YELLON DM, 1992, J MOL CELL CARDIOL, V24, P895, DOI 10.1016/0022-2828(92)91102-B
  134. YELLON DM, 1995, J MOL CELL CARDIOL, V27, P1023, DOI 10.1016/0022-2828(95)90071-3
  135. Yetgin T, 2015, JACC-CARDIOVASC INTE, V8, P1990, DOI 10.1016/j.jcin.2015.08.033
  136. Yi B, 2020, ANGIOLOGY, V71, P609, DOI 10.1177/0003319720919327
  137. Yue Y, 2001, AM J PHYSIOL-HEART C, V281, pH590, DOI 10.1152/ajpheart.2001.281.2.H590
  138. Yui H, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/521084
  139. Zaugg M, 2003, BRIT J ANAESTH, V91, P551, DOI 10.1093/bja/aeg205
  140. Zhang HX, 2006, J CARDIOVASC PHARM, V48, P306, DOI 10.1097/01.fjc.0000249873.73197.c3
  141. Zhang HF, 2004, APOPTOSIS, V9, P777, DOI 10.1023/B:APPT.0000045796.58715.82
  142. Brunton TL, 1867, LANCET, V90, P97, DOI 10.1016/S0140-6736(02)51392-1
  143. Kaeffer N, 1997, CIRCULATION, V96, P2311
  144. Zhang L, 2022, ACTA CARDIOL, DOI 10.1080/00015385.2021.2024701
  145. Zhang Q, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0641-7
  146. Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137775
  147. Zhao Y, 2014, CHEM COMMUN, V50, P11788, DOI 10.1039/c4cc00968a
  148. Zhen-Han L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10600-x
  149. Zheng Z, 2016, NEW ENGL J MED, V374, P1744, DOI 10.1056/NEJMoa1507750
  150. Zhou H, 2018, REDOX BIOL, V15, P335, DOI 10.1016/j.redox.2017.12.019
  151. Zhou JJ, 2001, AM J PHYSIOL-HEART C, V281, pH40, DOI 10.1152/ajpheart.2001.281.1.H40
  152. Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827
  153. Zuo YB, 2016, CELL PHYSIOL BIOCHEM, V39, P1021, DOI 10.1159/000447809
  154. Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1
  155. Bucciarelli-Ducci C, 2006, AM J CARDIOL, V98, P1349, DOI 10.1016/j.amjcard.2006.06.025
  156. Cai ZQ, 2013, P NATL ACAD SCI USA, V110, P17462, DOI 10.1073/pnas.1317158110
  157. Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098
  158. Castro PF, 2003, CRIT CARE MED, V31, P2152, DOI 10.1097/01.CCM.0000079604.46997.7B
  159. Ceremuzynski L, 1999, CARDIOVASC DRUG THER, V13, P191, DOI 10.1023/A:1007787924085
  160. Charan K, 2016, J SURG RES, V201, P272, DOI 10.1016/j.jss.2015.10.045
  161. Chaudhuri A, 2004, CIRCULATION, V109, P849, DOI 10.1161/01.CIR.0000116762.77804.FC
  162. Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955
  163. Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789
  164. Chinda K, 2012, DIABETES VASC DIS RE, V9, P256, DOI 10.1177/1479164112440816
  165. Karwi QG, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-017-0664-8
  166. Cho YJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020269
  167. Citi V, 2021, J ADV RES, V27, P41, DOI 10.1016/j.jare.2020.02.017
  168. Costa LMA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001161
  169. Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489
  170. D'Amario D, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4116-7
  171. Dai ZL, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-02287-w
  172. Dalal D, 2017, RHEUMATOL INT, V37, P2071, DOI 10.1007/s00296-017-3835-x
  173. Das S, 2002, DRUG EXP CLIN RES, V28, P213
  174. Daskalopoulou SS, 2008, EUR HEART J, V29, P2083, DOI 10.1093/eurheartj/ehn346
  175. Davidson SM, 2006, INT J BIOCHEM CELL B, V38, P414, DOI 10.1016/j.biocel.2005.09.017
  176. Kataoka Y, 2011, CIRC J, V75, P1968, DOI 10.1253/circj.CJ-11-0098
  177. De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009
  178. De Hert SG, 2003, ANESTHESIOLOGY, V99, P314, DOI 10.1097/00000542-200308000-00013
  179. de Peppo AP, 1999, ANN THORAC SURG, V68, P112, DOI 10.1016/S0003-4975(99)00466-X
  180. Deng W, 2014, ENDOCRINOLOGY, V155, P1618, DOI 10.1210/en.2013-1817
  181. DEVITA C, 1994, LANCET, V343, P1115
  182. Diaz R, 1998, CIRCULATION, V98, P2227, DOI 10.1161/01.CIR.98.21.2227
  183. Diaz R, 2007, JAMA-J AM MED ASSOC, V298, P2399, DOI 10.1001/jama.298.20.2399
  184. Diaz-Araya G, 2002, CRIT CARE MED, V30, P417, DOI 10.1097/00003246-200202000-00025
  185. Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516
  186. Eitel I, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030735
  187. Kavianipour M, 2003, PEPTIDES, V24, P569, DOI 10.1016/S0196-9781(03)00108-6
  188. El Messaoudi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096062
  189. Eriksson KE, 2021, BRIT J ANAESTH, V127, P547, DOI 10.1016/j.bja.2021.06.046
  190. Ezzat M.A.W., 2019, WORLD J CARDIOVASC D, V9, P707, DOI [10.4236/wjcd.2019.910064, DOI 10.4236/WJCD.2019.910064]
  191. Fan Y, 2011, EUR J CARDIO-THORAC, V40, P192, DOI 10.1016/j.ejcts.2010.10.007
  192. Fan Y, 2012, CLIN EXP PHARMACOL P, V39, P938, DOI 10.1111/1440-1681.12014
  193. Ferreira BMA, 2005, ANN NONINVAS ELECTRO, V10, P356, DOI 10.1111/j.1542-474X.2005.00650.x
  194. Fokkema ML, 2009, CIRC-CARDIOVASC INTE, V2, P323, DOI 10.1161/CIRCINTERVENTIONS.109.858977.109.858977
  195. Forbes RA, 2001, CIRC RES, V88, P802, DOI 10.1161/hh0801.089342
  196. Fryer RM, 2002, CARDIOVASC RES, V55, P520, DOI 10.1016/S0008-6363(02)00316-4
  197. Fuglesteg BN, 2009, ACTA PHYSIOL, V195, P273, DOI 10.1111/j.1748-1716.2008.01901.x
  198. Kawakita N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194623
  199. Gao Y, 2011, INT J CARDIOL, V152, P177, DOI 10.1016/j.ijcard.2010.07.012
  200. Gaster N, 2022, EUR HEART J-CARD PHA, V8, P282, DOI 10.1093/ehjcvp/pvab082
  201. Giblett Joel P, 2016, JACC Basic Transl Sci, V1, P267, DOI 10.1016/j.jacbts.2016.03.011
  202. Gori T, 2008, CLIN HEMORHEOL MICRO, V39, P191, DOI 10.3233/CH-2008-1081
  203. Gross ER, 2006, CARDIOVASC RES, V70, P212, DOI 10.1016/j.cardiores.2005.12.019
  204. Gu WD, 2008, ANESTHESIOLOGY, V108, P634, DOI 10.1097/ALN.0b013e3181672590
  205. Orriach JLG, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.06.004
  206. Guo Y, 2005, AM J PHYSIOL-HEART C, V289, pH2251, DOI 10.1152/ajpheart.00341.2005
  207. Guo YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041178
  208. HALE SL, 1993, CARDIOVASC RES, V27, P2140, DOI 10.1093/cvr/27.12.2140
  209. Kawamura T, 2005, SHOCK, V24, P103, DOI 10.1097/01.shk.0000168874.83401.3f
  210. Hamarneh A, 2015, CLIN CARDIOL, V38, P641, DOI 10.1002/clc.22445
  211. Hattori R, 2002, AM J PHYSIOL-HEART C, V282, pH1988, DOI 10.1152/ajpheart.01012.2001
  212. Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1
  213. Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5
  214. Hausenloy DJ, 2013, J CARDIOVASC PHARM T, V18, P263, DOI 10.1177/1074248412468945
  215. Hausenloy DJ, 2010, CARDIOVASC RES, V88, P67, DOI 10.1093/cvr/cvq113
  216. Hausenloy DJ, 2010, CARDIOVASC DRUG THER, V24, P235, DOI 10.1007/s10557-010-6237-9
  217. Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8
  218. Heidland UE, 2000, CORONARY ARTERY DIS, V11, P421, DOI 10.1097/00019501-200007000-00007
  219. Hennan JK, 2001, CIRCULATION, V104, P820, DOI 10.1161/hc3301.092790
  220. Kim JW, 2014, KOREAN CIRC J, V44, P76, DOI 10.4070/kcj.2014.44.2.76
  221. Heusch G, 2001, CIRCULATION, V103, P2876, DOI 10.1161/01.CIR.103.24.2876
  222. Hong L, 2012, EUR J PHARMACOL, V695, P13, DOI 10.1016/j.ejphar.2012.07.053
  223. HORWITZ LD, 1994, CIRCULATION, V89, P1792, DOI 10.1161/01.CIR.89.4.1792
  224. Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1
  225. Hu YR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203315
  226. Hu ZY, 2009, ANAESTH INTENS CARE, V37, P532, DOI 10.1177/0310057X0903700402
  227. Hu ZY, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-021-01392-6
  228. Huang MH, 2011, CARDIOVASC DRUG THER, V25, P223, DOI 10.1007/s10557-011-6302-z
  229. Hueb W, 2007, CORONARY ARTERY DIS, V18, P55, DOI 10.1097/MCA.0b013e328011c0a9
  230. Oidor-Chan VH, 2016, PPAR RES, V2016, DOI 10.1155/2016/8237264
  231. KITAKAZE M, 1994, J CLIN INVEST, V93, P2197, DOI 10.1172/JCI117216
  232. Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1
  233. BANERJEE A, 1993, CIRC RES, V73, P656, DOI 10.1161/01.RES.73.4.656
  234. Klepzig H, 1999, EUR HEART J, V20, P439, DOI 10.1053/euhj.1998.1242
  235. Kristensen J, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-31
  236. Krljanac G, 2005, AM J CARDIOL, V96, P1053, DOI 10.1016/j.amjcard.2005.05.068
  237. Kuga H, 2003, CIRC J, V67, P443
  238. Kuhn M, 2015, CIRC RES, V116, P1278, DOI 10.1161/CIRCRESAHA.115.306325
  239. Kukreja RC, 2011, EXP CLIN CARDIOL, V16, pE30
  240. Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510
  241. KUZUYA T, 1993, CIRC RES, V72, P1293, DOI 10.1161/01.RES.72.6.1293
  242. Lalonde F, 2015, EUR J PREV CARDIOL, V22, P100, DOI 10.1177/2047487313502447
  243. Landoni G, 2019, NEW ENGL J MED, V380, P1214, DOI 10.1056/NEJMoa1816476
  244. Banerjee S, 1999, AM J PHYSIOL-HEART C, V277, pH2488, DOI 10.1152/ajpheart.1999.277.6.H2488
  245. Lascano EC, 2007, SCAND CARDIOVASC J, V41, P160, DOI 10.1080/14017430701329295
  246. Lasley RD, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00310
  247. Lazzari FD, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101884
  248. Ledoux S, 2002, CIRC RES, V90, P420, DOI 10.1161/hh0402.105668
  249. Lee TM, 2003, J CLIN ENDOCR METAB, V88, P531, DOI 10.1210/jc.2002-020904
  250. Lee TM, 2017, FREE RADICAL BIO MED, V104, P298, DOI 10.1016/j.freeradbiomed.2017.01.035
  251. Leesar MA, 1999, J AM COLL CARDIOL, V34, P639, DOI 10.1016/S0735-1097(99)00297-1
  252. Leesar MA, 1997, CIRCULATION, V95, P2500, DOI 10.1161/01.CIR.95.11.2500
  253. Leesar MA, 2001, CIRCULATION, V103, P2935, DOI 10.1161/01.CIR.103.24.2935
  254. Lincoff AM, 2014, EUR HEART J, V35, P2516, DOI 10.1093/eurheartj/ehu177
  255. BANKWALA Z, 1994, CIRCULATION, V90, P1023, DOI 10.1161/01.CIR.90.2.1023
  256. LIU GS, 1991, CIRCULATION, V84, P350, DOI 10.1161/01.CIR.84.1.350
  257. Liu XG, 2018, BRIT J CLIN PHARMACO, V84, P1180, DOI 10.1111/bcp.13536
  258. Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309
  259. Loubani M, 2005, EUR J PHARMACOL, V515, P142, DOI 10.1016/j.ejphar.2005.04.002
  260. Ludman AJ, 2011, HEART, V97, P1560, DOI 10.1136/hrt.2011.223867
  261. Ma N, 2016, MOL MED REP, V14, P4216, DOI 10.3892/mmr.2016.5773
  262. Maddock HL, 2004, CARDIOVASC DRUG THER, V18, P113, DOI 10.1023/B:CARD.0000029028.75316.5e
  263. Mahaffey KW, 1999, J AM COLL CARDIOL, V34, P1711, DOI 10.1016/S0735-1097(99)00418-0
  264. Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199
  265. Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512
  266. Bao N, 2009, J CARDIOL, V53, P102, DOI 10.1016/j.jjcc.2008.09.012
  267. MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K
  268. Mamas MA, 2010, EXP CLIN CARDIOL, V15, pE20
  269. Marenzi G, 2015, AM J CARDIOL, V116, P1791, DOI 10.1016/j.amjcard.2015.09.016
  270. Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901
  271. Masclee GMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204746
  272. Matsubara T, 2000, J AM COLL CARDIOL, V35, P345, DOI 10.1016/S0735-1097(99)00539-2
  273. McCormick LM, 2014, CIRC-CARDIOVASC IMAG, V7, P274, DOI 10.1161/CIRCIMAGING.113.000785
  274. McPherson BC, 2001, CIRCULATION, V103, P290
  275. Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437
  276. MENASCHE P, 1995, J THORAC CARDIOV SUR, V110, P1096, DOI 10.1016/S0022-5223(05)80179-5
  277. Basnet S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002314
  278. Mendieta G, 2020, J AM COLL CARDIOL, V75, P1386, DOI 10.1016/j.jacc.2020.01.042
  279. Mentzer RM, 1999, ANN SURG, V229, P643, DOI 10.1097/00000658-199905000-00006
  280. Minamino T, 2018, CIRC J, V82, P1083, DOI 10.1253/circj.CJ-17-0889
  281. Miyaji Y, 2011, DRUG METAB DISPOS, V39, P1946, DOI 10.1124/dmd.111.040725
  282. MIZUMURA T, 1995, CARDIOVASC RES, V29, P482
  283. Mocanu MM, 2001, CIRCULATION, V103, P3111, DOI 10.1161/01.CIR.103.25.3111
  284. Mocini D, 2008, PERFUSION-UK, V23, P187, DOI 10.1177/0267659108097627
  285. Moritz K. M., 1997, American Journal of Physiology, V273, pR1829
  286. Morris SD, 1997, J AM COLL CARDIOL, V29, P1599, DOI 10.1016/S0735-1097(97)00087-9
  287. Murphy GS, 2006, J CARDIOTHOR VASC AN, V20, P493, DOI 10.1053/j.jvca.2005.07.036
  288. Belhomme D, 1999, CIRCULATION, V100, P340
  289. MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
  290. Murry CE, 1988, CIRCULATION, V78, pAbs II
  291. Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592
  292. Nanhwan MK, 2014, ARTERIOSCL THROM VAS, V34, P2078, DOI 10.1161/ATVBAHA.114.304002
  293. Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925
  294. Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58
  295. Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002
  296. Ohman J, 2012, BIOCHEM BIOPH RES CO, V418, P754, DOI 10.1016/j.bbrc.2012.01.093
  297. Okubo S, 2004, AM J PHYSIOL-HEART C, V287, pH1786, DOI 10.1152/ajpheart.01143.2003
  298. Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003
  299. Bell RM, 2003, J AM COLL CARDIOL, V41, P508, DOI 10.1016/S0735-1097(02)02816-4
  300. Ott I, 2010, CIRC-CARDIOVASC INTE, V3, P408, DOI 10.1161/CIRCINTERVENTIONS.109.904425

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - ODS/03